NSE - Delayed Quote
INR
Piramal Pharma Limited (PPLPHARMA.NS)
237.77
+6.99
(+3.03%)
At close: October 30 at 3:29:59 PM GMT+5:30
Loading chart for PPLPHARMA.NS
- Previous Close
230.78 - Open
229.95 - Bid --
- Ask 238.91 x --
- Day's Range
225.82 - 240.00 - 52 Week Range
132.30 - 240.00 - Volume
26,855,814 - Avg. Volume
6,445,192 - Market Cap (intraday)
315.303B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
-- - EPS (TTM)
-1.58 - Earnings Date (est.) Jan 27, 2027
- Forward Dividend & Yield 0.14 (0.00%)
- Ex-Dividend Date Jul 16, 2025
- 1y Target Est
260.09
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
PPLPHARMA.NS
38.07%
S&P BSE SENSEX (^BSESN)
12.63%
1-Year Return
PPLPHARMA.NS
17.77%
S&P BSE SENSEX (^BSESN)
11.78%
3-Year Return
PPLPHARMA.NS
149.45%
S&P BSE SENSEX (^BSESN)
16.14%
5-Year Return
PPLPHARMA.NS
21.74%
S&P BSE SENSEX (^BSESN)
25.55%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-2.14%
-
Return on Assets (ttm)
1.14%
-
Return on Equity (ttm)
-2.58%
-
Revenue (ttm)
97.79B
-
Net Income Avi to Common (ttm)
-2.09B
-
Diluted EPS (ttm)
-1.58
Balance Sheet and Cash Flow
-
Total Cash (mrq)
8.3B
-
Total Debt/Equity (mrq)
71.93%
-
Levered Free Cash Flow (ttm)
-4.45B
